Barely Significant
← all excerpts

High-throughput screening of drug libraries identifies a new synergistic drug combination for the treatment of retinoblastoma.

PLoS One · 2026 · PMC12935222 · PMID 41739835

1
hedged sentence
closest p
boldest claim

The sentences

Among the evaluated drug combinations, carboplatin-gemcitabine exhibited an increase in average synergy score (δ avg ) from 18.75 at 37 °C to 27.53 at 42 °C, although this trend did not reach statistical significance ( S6 Table ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.